Company Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 03:25:03 2025-01-22 pm EST			5-day change	1st Jan Change
754.74 ^USD	+1.67%		+1.10%	-2.21%

09:56am	Jefferies Adjusts Price Target on Eli Lilly to $1,020 From $996	MT
04:35am	Robeco Global Consumer Trends down 0.37% in December - up in Novo Nordisk and Eli Lilly	FW

Business description: Eli Lilly and Company

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:

- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;

- oncology (19.5%);

- immunology diseases (11.1%);

- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;

- other (3.3%).

Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).

Number of employees: 43,000

Sales by Activity: Eli Lilly and Company

Fiscal Period: December	2019	2020	2021	2022	2023
Discovery, Dev., Manufacturing, Marketing, and Sales of Pharmaceutical Products	22.32B	24.54B	28.32B	28.54B	34.12B

See all business segments

Geographical breakdown of sales: Eli Lilly and Company

Fiscal Period: December	2019	2020	2021	2022	2023
United States (U.S.)	12.72B	14.23B	16.81B	18.19B	21.79B
Europe	3.76B	4.19B	4.78B	4.3B	6.17B
Other Foreign Countries	3.28B	2.42B	2.7B	2.85B	2.95B
Japan	2.55B	2.58B	2.37B	1.75B	1.67B
China	-	1.12B	1.66B	1.45B	1.54B

See all geographic segments

Managers: Eli Lilly and Company

Director	Title	Age	Since
David Ricks CEO	Chief Executive Officer	57	2016-12-31
Ruth Gimeno PSD	President	-	-
Lucas Montarce DFI	Director of Finance/CFO	48	2024-09-08
David Hyman CTO	Chief Tech/Sci/R&D Officer	-	2023-10-15
Daniel Skovronsky CTO	Chief Tech/Sci/R&D Officer	51	-

See ELI LILLY AND COMPANY governance

Members of the board: Eli Lilly and Company

Manager	Title	Age	Since
Jon Fyrwald BRD	Director/Board Member	64	2004-12-31
Ralph Alvarez BRD	Director/Board Member	68	2009-03-31
Katherine Baicker BRD	Director/Board Member	53	2011-12-11
David Ricks CHM	Chairman	57	2017-05-31
William Kaelin BRD	Director/Board Member	67	2012-06-03
Juan Luciano BRD	Director/Board Member	63	2016-01-31
Jamere Jackson BRD	Director/Board Member	55	2016-09-30
Gabrielle Greene-Sulzberger BRD	Director/Board Member	64	2021-01-24
Kimberly Johnson BRD	Director/Board Member	52	2021-02-15
Mary Lynne Hedley BRD	Director/Board Member	62	2022-05-14

Composition of the Board of Directors

Shareholders: Eli Lilly and Company

Name	Equities	%	Valuation
Lilly Endowment, Inc. 10.21 %	96,891,978	10.21 %	74 801 M $
Lilly Endowment, Inc. 10.21 %	96,891,978	10.21 %	74 801 M $
Vanguard Fiduciary Trust Co. 7.771 %	73,773,467	7.771 %	56 953 M $
PNC Investments LLC 5.410 %	51,360,730	5.410 %	39 650 M $
BlackRock Advisors LLC 5.204 %	49,405,376	5.204 %	38 141 M $

Name	Equities	%	Valuation
Caixa DTVM SA 0.001356 %	386,450	0.001356 %	10 M $
Western Asset Management Company DTVM Ltda. 0.000646 %	184,226	0.000646 %	5 M $
BRAM - Bradesco Asset Management SA DTVM 0.000178 %	50,620	0.000178 %	1 M $
Safra Asset Management Ltda. 0.000126 %	35,800	0.000126 %	918 872 $
XP Allocation Asset Management Ltda. 0.000045 %	12,866	0.000045 %	330 229 $

List of ELI LILLY AND COMPANY shareholders

Holdings: Eli Lilly and Company

Name	Equities	%	Valuation
PROQR THERAPEUTICS N.V. 12.96%	13,371,562	12.96%	35,434,639 $
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. 3.27%	6,097,792	3.27%	34,644,056 $
FOGHORN THERAPEUTICS INC. 7.20%	4,000,000	7.20%	18,880,000 $
PRISM BIOLAB CO.,LTD 6.95%	2,500,000	6.95%	4,611,950 $

Company details: Eli Lilly and Company

Eli Lilly & Co.

Lilly Corporate Center

46285, Indianapolis

+317 276 2000

http://www.lilly.com

Group companies: Eli Lilly and Company

Name	Category and Sector
Lilly Global Nederland Holdings BV Lilly Global Nederland Holdings BV Financial ConglomeratesFinance Part of Eli Lilly & Co., Lilly Global Nederland Holdings BV functions as an investment holding Dutch company. The company is based in Utrecht, Netherlands.	Financial Conglomerates
Eli Lilly Kinsale Ltd. Eli Lilly Kinsale Ltd. Pharmaceuticals: OtherHealth Technology Eli Lilly Kinsale Ltd., part of Eli Lilly & Co., is a company headquartered in Kinsale, Ireland, that manufactures medicines.	Pharmaceuticals: Other
Lilly Ventures Fund I LLC Lilly Ventures Fund I LLC Investment ManagersFinance Lilly Ventures Fund I LLC seeks investment opportunities located in the North American and European regions. The fund targets companies operating in the fields of biotechnology, medical technology and healthcare IT. It provides financing for early stage capital requirements.	Investment Managers
Eli Lilly Vostok SA
Eli Lilly (Suisse) SA	Miscellaneous Commercial Services

See all subsidiaries

Other Pharmaceuticals

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
ELI LILLY AND COMPANY	+1.19%	+0.73%	+19.23%	+212.88%	668B
JOHNSON & JOHNSON	-2.48%	-0.52%	-11.24%	-11.51%	357B
NOVO NORDISK A/S	+1.39%	-3.87%	-19.96%	+91.03%	356B
ABBVIE INC.	-1.26%	-0.48%	+3.10%	+29.03%	305B
MERCK & CO., INC.	-0.24%	-4.08%	-19.61%	+21.79%	243B
ROCHE HOLDING AG	+1.33%	+2.97%	+10.49%	-20.58%	240B
ASTRAZENECA PLC	-0.11%	+3.68%	+4.25%	+32.76%	211B
NOVARTIS AG	+0.41%	-0.94%	-4.95%	+16.91%	197B
PFIZER, INC.	-1.71%	+0.09%	-7.30%	-49.08%	151B
AMGEN INC.	-0.19%	+1.93%	-11.62%	+21.25%	148B
Average	-0.19%	+0.32%	-3.76%	+34.45%	287.56B
Weighted average by Cap.	+0.00%	-0.00%	-0.85%	+64.60%